Literature DB >> 18298592

N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload.

Aaron A R Tobian1, Lori J Sokoll, Daniel J Tisch, Paul M Ness, Hua Shan.   

Abstract

BACKGROUND: Transfusion-associated circulatory overload (TACO) can be difficult to diagnose and distinguish from transfusion-related acute lung injury (TRALI), but is a relatively common complication that occurs when increases in blood volume overwhelm the cardiovascular system. Brain natriuretic peptide (BNP) has been shown to be a functional marker for TACO. N-terminal pro-brain natriuretic peptide (NT-proBNP) is another marker that could be more helpful than BNP since it has a longer half-life in circulation and is also much more stable in laboratory samples. In this study, whether NT-proBNP is a useful diagnostic marker for TACO was evaluated. STUDY DESIGN AND METHODS: Forty patients were enrolled into a case-control study (16 patients with TACO and 24 control patients) and had pre- and posttransfusion NT-proBNP concentrations evaluated from submitted type-and-screen blood samples.
RESULTS: The sensitivity of elevated posttransfusion NT-proBNP to diagnose TACO was 93.8 percent, the specificity was 83.8 percent, and the accuracy was 87.5 percent. Elevated posttransfusion NT-proBNP is the only independent variable for the diagnosis of TACO based on multivariate logistic regression.
CONCLUSION: NT-proBNP is both a sensitive and a specific marker for TACO and can be helpful in confirming transfusion associated fluid overload. This study also demonstrates that many patients who experience TACO may already be in a state of excess volume. Clinicians should be aware that many asymptomatic patients have excess fluid and transfusion may cause these patients to become symptomatic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298592     DOI: 10.1111/j.1537-2995.2008.01656.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  14 in total

1.  Insufficient nitric oxide bioavailability: a hypothesis to explain adverse effects of red blood cell transfusion.

Authors:  John D Roback; Robert B Neuman; Arshed Quyyumi; Roy Sutliff
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

Review 2.  Pulmonary transfusion reactions.

Authors:  Jürgen Bux; Ulrich J H Sachs
Journal:  Transfus Med Hemother       Date:  2008-09-18       Impact factor: 3.747

3.  N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity.

Authors:  Christoph Bührer; Ömer Erdeve; Anton van Kaam; Angelika Berger; Evelyn Lechner; Benjamin Bar-Oz; Karel Allegaert; Tom Stiris; İstemi Han Çelik; Janet Berrington
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

4.  Dynamic detection of N-terminal pro-B-type natriuretic peptide helps to predict the outcome of patients with major trauma.

Authors:  A Qian; M Zhang; G Zhao
Journal:  Eur J Trauma Emerg Surg       Date:  2014-06-03       Impact factor: 3.693

5.  Differentiating pulmonary transfusion reactions using recipient and transfusion factors.

Authors:  Nareg H Roubinian; Mark R Looney; Sheila Keating; Daryl J Kor; Clifford A Lowell; Ognjen Gajic; Rolf Hubmayr; Michael Gropper; Monique Koenigsberg; Gregory A Wilson; Michael A Matthay; Pearl Toy; Edward L Murphy
Journal:  Transfusion       Date:  2017-05-03       Impact factor: 3.157

Review 6.  Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill.

Authors:  Alexander B Benson; Marc Moss; Christopher C Silliman
Journal:  Br J Haematol       Date:  2009-08-05       Impact factor: 6.998

7.  The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill.

Authors:  Guangxi Li; Craig E Daniels; Marija Kojicic; Tami Krpata; Greg A Wilson; Jeffrey L Winters; S Breanndan Moore; Ognjen Gajic
Journal:  Transfusion       Date:  2008-10-14       Impact factor: 3.157

Review 8.  Interpretation and use of natriuretic peptides in non-congestive heart failure settings.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Shi-Jye Chu; Ching-Wang Hsu; Shu-Meng Cheng
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

9.  Risk factors and outcomes in transfusion-associated circulatory overload.

Authors:  Edward L Murphy; Nicholas Kwaan; Mark R Looney; Ognjen Gajic; Rolf D Hubmayr; Michael A Gropper; Monique Koenigsberg; Greg Wilson; Michael Matthay; Peter Bacchetti; Pearl Toy
Journal:  Am J Med       Date:  2013-01-26       Impact factor: 4.965

10.  Pulmonary complications of transfused blood components.

Authors:  Alexander B Benson
Journal:  Crit Care Nurs Clin North Am       Date:  2012-09       Impact factor: 1.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.